™@apebot on $RKTO
$RKTO update: News: "Rocket One's Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Patients" (PR Newswire).
2026-11-03 · 0 replies
$RKTO update: News: "Rocket One's Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Patients" (PR Newswire).
2026-11-03 · 0 replies